- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MH-33-0029000

Cross Vision Pharma Private Limited
About Cross Vision Pharma Private Limited
Data last updated:
Cross Vision Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 13 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2020PTC341838.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Niyaz Ahmad Vaid and Arshad Ahmad Mir.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 503 Jay Saraswati Chs Ltd Evershine Enclave Nr Bazaz Cinema Mira Road(E), Mumbai, Maharashtra, India – 401107.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.46 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹864 (net margin 0%) and EBITDA of ₹33,867 (EBITDA margin 1.4%). Revenue has grown at a compounded annual rate (CAGR) of 68% over three years.
Cross Vision Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0029000).
Company details
Recognitions & Rankings of Cross Vision Pharma
Contact details
Cross Vision Pharma Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressA – 503 Jay Saraswati Chs Ltd Evershine Enclave Nr Bazaz Cinema Mira Road(E), Mumbai, Maharashtra, India – 401107
- IndustryChemicals, Manufacturing, Basic Chemical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cross Vision Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Cross Vision Pharma Private Limited, buy the company report.
Financials of Cross Vision Pharma Private Limited
FY 2025 filings availableCross Vision Pharma Private Limited reported revenue of ₹23.46 Lakh (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 68% over three years, including 10% growth in the latest year. EBITDA fell 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹33,867 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹864 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 0% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cross Vision Pharma Private Limited, buy the company report.
Board of directors of Cross Vision Pharma Private Limited
Cross Vision Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Niyaz Ahmad Vaid | Director | 13 Jul 2020 | 6 Years 4 Months | Current |
| Arshad Ahmad Mir | Director | 13 Jul 2020 | 6 Years 4 Months | Current |
| Sameer Ahmad Shah | Director | 13 Jul 2020 | 6 Years 4 Months | Current |
Peer comparison
Cross Vision Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Le-Milieu Fasion Private Limited | ₹23.49 Lakh (FY 2025) | 243.0% | Vadodara, Gujarat, India | |||
| Ambiz India Nutrition and Drugs Private Limited | ₹23.49 Lakh (FY 2025) | 1.0% | Nagpur, Maharashtra, India | |||
| Xcut Technologies Private Limited | ₹23.47 Lakh (FY 2024) | -61.0% | Mumbai, Maharashtra, India | |||
| Saras Vanijya Private Limited | ₹23.47 Lakh (FY 2025) | -25.0% | Kolkata, West Bengal, India | |||
| Apay Retails Private Limited | ₹23.46 Lakh (FY 2025) | 39.0% | Delhi, India | |||
| Cross Vision Pharma Private Limitedthis company | ₹23.46 Lakh (FY 2025) | ₹864 | 0% | 10.0% | Mumbai, Maharashtra, India | |
| Silvertone Printing & Packaging Private Limited | ₹23.43 Lakh (FY 2024) | -22.0% | Delhi, India | |||
| Kwality-Corporate Bakers Private Limited | ₹23.41 Lakh (FY 2024) | Patna, Bihar, India | ||||
| Integrated Pneumatic Controls Private Limited | ₹23.38 Lakh (FY 2024) | Kanchipuram, Tamil Nadu, India | ||||
| R N Overseas Private Limited | ₹23.34 Lakh (FY 2025) | -44.0% | Siliguri, West Bengal, India | |||
| Sharma Developers Private Limited | ₹23.32 Lakh (FY 2025) | Mumbai, Maharashtra, India |
To see the full peer comparison of Cross Vision Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cross Vision Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cross Vision Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Cross Vision Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Cross Vision Pharma Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Arshad Ahmad Mir was appointed as Director on 13 Jul 2020.
Frequently asked questions
Cross Vision Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 13 July 2020 (6+ years old) and is registered under CIN U24100MH2020PTC341838.
Cross Vision Pharma has 3 current directors:
- Niyaz Ahmad Vaid - Director
- Arshad Ahmad Mir - Director
- Sameer Ahmad Shah - Director
The latest financial statements of Cross Vision Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Cross Vision Pharma is U24100MH2020PTC341838. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cross Vision Pharma was incorporated on 13 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Cross Vision Pharma by revenue are Le-Milieu Fasion Private Limited, Ambiz India Nutrition and Drugs Private Limited, Xcut Technologies Private Limited, Saras Vanijya Private Limited, Apay Retails Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Arshad Ahmad Mir was appointed as Director on 13 Jul 2020. Niyaz Ahmad Vaid was appointed as Director on 13 Jul 2020. Sameer Ahmad Shah was appointed as Director on 13 Jul 2020.
Yes, Cross Vision Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0029000).
The registered office of Cross Vision Pharma is at A – 503 Jay Saraswati Chs Ltd Evershine Enclave Nr Bazaz Cinema Mira RoadE, Mumbai, Maharashtra, India – 401107.
Cross Vision Pharma operates in the chemicals industry, in the manufacturing segment.
Cross Vision Pharma can be reached at its registered office: A – 503 Jay Saraswati Chs Ltd Evershine Enclave Nr Bazaz Cinema Mira RoadE, Mumbai, Maharashtra, India – 401107.

